SVRA — Savara Inc
NASDAQ · Healthcare · Biotechnology
$5.61
+$0.01 (+0.18%)
Savara Inc (SVRA) is a biotechnology company listed on NASDAQ. It is led by Matthew Pauls J.D., M.B.A., based in 1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047, with about 70 employees. Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Net income was -$86.6M. SVRA currently screens at market cap $1.11B.
Use this SVRA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SVRA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SVRA SEC filings page. Lician reads the product cache first so this HTML stays unique to Savara Inc even when a live quote feed is slow.
About Savara Inc
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
SVRA Key Statistics
Market Cap
$1.11B
Volume
1.53M
Previous Close
$5.60
Day Range
$5.51 – $5.68
P/B Ratio
6.17
EPS
-$0.48
Revenue
$0.00
Net Income
-$95.88M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
70
SVRA Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$95.88M | -$54.70M | -$38.15M | -$43.01M |
| EPS (Diluted) | -$0.48 | -$0.33 | -$0.25 | -$0.32 |
Total Assets
$212.88M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$15.13M
Operating Cash Flow
-$89.09M
Free Cash Flow
$0.00
Savara Inc Company Information
- Chairman & CEO
- Matthew Pauls J.D., M.B.A.
- Headquarters
- 1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047
- Website
- www.savarapharma.com
- Phone
- 512 614 1848
- IPO / Founded
- 2017-06-01
- Sector
- Healthcare
- Industry
- Biotechnology